These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2619 related items for PubMed ID: 15776115

  • 41. The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education.
    Arepally G, Bauer KA, Bhatt DL, Merli GJ, Naccarelli GV, Carter RD, Karcher RB, Berry CA, Keaton KL, Stowell SA.
    Crit Pathw Cardiol; 2010 Mar; 9(1):41-8. PubMed ID: 20215910
    [Abstract] [Full Text] [Related]

  • 42. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG, Albers GW.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):929-35. PubMed ID: 15028346
    [Abstract] [Full Text] [Related]

  • 43. Antithrombotic therapy in atrial fibrillation.
    Turpie AG, Connolly SJ.
    Can Fam Physician; 1996 Jul 17; 42():1341-5. PubMed ID: 8754703
    [Abstract] [Full Text] [Related]

  • 44. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP.
    Europace; 2014 Mar 17; 16(3):308-19. PubMed ID: 24351881
    [Abstract] [Full Text] [Related]

  • 45. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].
    Reicke B, Masuhr F, Weih M.
    Fortschr Neurol Psychiatr; 2008 Jul 17; 76(7):391-5. PubMed ID: 18604772
    [Abstract] [Full Text] [Related]

  • 46. General practitioners' approach to hypertension in urban Pakistan: disturbing trends in practice.
    Jafar TH, Jessani S, Jafary FH, Ishaq M, Orakzai R, Orakzai S, Levey AS, Chaturvedi N.
    Circulation; 2005 Mar 15; 111(10):1278-83. PubMed ID: 15769769
    [Abstract] [Full Text] [Related]

  • 47. [The practice guideline 'atrial fibrillation' from the Dutch College of General Practitioners; a response from the perspective of cardiology].
    Crijns HJ.
    Ned Tijdschr Geneeskd; 2004 Jul 17; 148(29):1425-6. PubMed ID: 15326643
    [Abstract] [Full Text] [Related]

  • 48. The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.
    Bungard TJ, Ghali WA, McAlister FA, Buchan AM, Cave AJ, Hamilton PG, Mitchell LB, Shuaib A, Teo KK, Tsuyuki RT.
    Can J Cardiol; 2003 Mar 15; 19(3):280-4. PubMed ID: 12677283
    [Abstract] [Full Text] [Related]

  • 49. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics.
    Choudhry NK, Soumerai SB, Normand SL, Ross-Degnan D, Laupacis A, Anderson GM.
    Am J Med; 2006 Jul 15; 119(7):607-15. PubMed ID: 16828633
    [Abstract] [Full Text] [Related]

  • 50. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V, Legnani C, Noventa F, Palareti G, ISCOAT Study Group.(Italian Study on Complications of Oral Anticoagulant Therapy).
    Thromb Haemost; 2001 Mar 15; 85(3):418-22. PubMed ID: 11307807
    [Abstract] [Full Text] [Related]

  • 51. Primary care physicians' perceptions of adolescent pregnancy and STD prevention practices in a Nova Scotia county.
    Langille DB, Mann KV, Gailiunas PN.
    Am J Prev Med; 1997 Mar 15; 13(4):324-30. PubMed ID: 9236972
    [Abstract] [Full Text] [Related]

  • 52. Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France.
    FALSTAF Study GroupService de Pharmacologie Clinique, EA 3736, Faculté R.T.H. Laennec, Université Lyon 1, Rue Guillaume Paradin, BP 8071-69376 LYON cedex 08, France., Leizorovicz A, Cohen A, Guenoun M, Mismetti P, Weisslinger N.
    Pharmacoepidemiol Drug Saf; 2007 Jan 15; 16(1):32-8. PubMed ID: 17063535
    [Abstract] [Full Text] [Related]

  • 53. [Antithrombotic treatment of atrial fibrillation in hospital].
    Thomassen G, Hansen MS, Nordøy A, Hansen JB.
    Tidsskr Nor Laegeforen; 2001 Oct 10; 121(24):2800-4. PubMed ID: 11706483
    [Abstract] [Full Text] [Related]

  • 54. Is warfarin underused in the treatment of elderly persons with atrial fibrillation?
    Whittle J, Wickenheiser L, Venditti LN.
    Arch Intern Med; 1997 Feb 24; 157(4):441-5. PubMed ID: 9046896
    [Abstract] [Full Text] [Related]

  • 55. Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans.
    Ohlmeier C, Mikolajczyk R, Haverkamp W, Garbe E.
    Europace; 2013 Oct 24; 15(10):1436-44. PubMed ID: 23487542
    [Abstract] [Full Text] [Related]

  • 56. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U, Lindbäck J, Wallentin L, RIKS-HIA Registry.
    Circulation; 2005 Nov 22; 112(21):3225-31. PubMed ID: 16301355
    [Abstract] [Full Text] [Related]

  • 57. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Ho SF, O'Mahony MS, Steward JA, Burr ML, Buchalter M.
    Age Ageing; 2004 Sep 22; 33(5):488-92. PubMed ID: 15271642
    [Abstract] [Full Text] [Related]

  • 58. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention.
    Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM.
    J Am Geriatr Soc; 2005 Nov 22; 53(11):1912-20. PubMed ID: 16274372
    [Abstract] [Full Text] [Related]

  • 59. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
    Burkiewicz JS.
    Pharmacotherapy; 2005 Aug 22; 25(8):1062-7. PubMed ID: 16207096
    [Abstract] [Full Text] [Related]

  • 60. Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.
    Man-Son-Hing M, Gage BF, Montgomery AA, Howitt A, Thomson R, Devereaux PJ, Protheroe J, Fahey T, Armstrong D, Laupacis A.
    Med Decis Making; 2005 Aug 22; 25(5):548-59. PubMed ID: 16160210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 131.